Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Ingrid Ljuslinder"'
Autor:
Thyra Löwenmark, Linda Köhn, Therese Kellgren, William Rosenbaum, Vicky Bronnec, Anna Löfgren-Burström, Carl Zingmark, Pär Larsson, Michael Dahlberg, Bjoern O. Schroeder, Sun Nyunt Wai, Ingrid Ljuslinder, Sofia Edin, Richard Palmqvist
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background Mounting evidence suggests a significant role of the gut microbiota in the development and progression of colorectal cancer (CRC). In particular, an over-representation of oral pathogens has been linked to CRC. The aim of this stu
Externí odkaz:
https://doaj.org/article/ab4a5d7d5cbf4cc6839846159d00013c
Autor:
Bengt Glimelius, Tanweera Khan, Karin Adolfsson, Eva Angenete, Åke Berglund, Kristina Bonde, Nils Elander, Tone Fokstuen, Johan Haux, Israa Imam, Cecilia Lagerbäck, Ingrid Ljuslinder, Andrzej Piwowar, Marie Zajicova, Per J. Nilsson
Publikováno v:
EClinicalMedicine, Vol 75, Iss , Pp 102771- (2024)
Summary: Background: Total neoadjuvant treatment (TNT) for locally advanced rectal cancer (LARC) increases pathologic complete response (pCR) rate and reduces the risk of systemic recurrences over chemoradiotherapy (CRT) in randomised trials, e.g., t
Externí odkaz:
https://doaj.org/article/e883f34623c44a3b9ec58bd2e18a9b0d
Autor:
Lars Ny, Henrik Jespersen, Joakim Karlsson, Samuel Alsén, Stefan Filges, Charlotta All-Eriksson, Bengt Andersson, Ana Carneiro, Hildur Helgadottir, Max Levin, Ingrid Ljuslinder, Roger Olofsson Bagge, Vasu R. Sah, Ulrika Stierner, Anders Ståhlberg, Gustav Ullenhag, Lisa M. Nilsson, Jonas A. Nilsson
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
The authors report the results of the phase II PEMDAC clinical study testing the combination of the HDAC inhibitor entinostat with the anti- PD-1 antibody pembrolizumab in uveal melanoma. Low tumor burden, a wildtype BAP1 gene in the tumor or iris me
Externí odkaz:
https://doaj.org/article/81ef06cf1a674812b72c3509644a228b
Autor:
Miriam K. Rutegård, Malin Båtsman, Lennart Blomqvist, Martin Rutegård, Jan Axelsson, Ingrid Ljuslinder, Jörgen Rutegård, Richard Palmqvist, Fredrik Brännström, Patrik Brynolfsson, Katrine Riklund
Publikováno v:
Cancer Imaging, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Purpose To enable the evaluation of locoregional disease in the on-going RECTOPET (REctal Cancer Trial on PET/MRI/CT) study; a methodology to match mesorectal imaging findings to histopathology is presented, along with initial observations.
Externí odkaz:
https://doaj.org/article/c1938c65e57e4114b8177e01056bb605
Autor:
Mahmood Faraz, Andreas Tellström, Christina Edwinsdotter Ardnor, Kjell Grankvist, Lukasz Huminiecki, Björn Tavelin, Roger Henriksson, Håkan Hedman, Ingrid Ljuslinder
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) copy number alterations and unbalanced gene recombination events have been reported to occur in breast cancer. Importantly, LRIG1 loss was recently shown to predict ea
Externí odkaz:
https://doaj.org/article/deae4120240c4efd9609f400a550d352
Autor:
Miriam K. Rutegård, Malin Båtsman, Jan Axelsson, Patrik Brynolfsson, Fredrik Brännström, Jörgen Rutegård, Ingrid Ljuslinder, Lennart Blomqvist, Richard Palmqvist, Martin Rutegård, Katrine Riklund
Publikováno v:
Cancer Imaging, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Purpose The role of hybrid imaging using 18F-fluoro-2-deoxy-D-glucose positron-emission tomography (FDG-PET), computed tomography (CT) and magnetic resonance imaging (MRI) to improve preoperative evaluation of rectal cancer is largely unknow
Externí odkaz:
https://doaj.org/article/1c0c756f8d1c4b09916c929a400acade
Autor:
Henrik Jespersen, Roger Olofsson Bagge, Gustav Ullenhag, Ana Carneiro, Hildur Helgadottir, Ingrid Ljuslinder, Max Levin, Charlotta All-Eriksson, Bengt Andersson, Ulrika Stierner, Lisa M. Nilsson, Jonas A. Nilsson, Lars Ny
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background While recent years have seen a revolution in the treatment of metastatic cutaneous melanoma, no treatment has yet been able to demonstrate any prolonged survival in metastatic uveal melanoma. Thus, metastatic uveal melanoma remain
Externí odkaz:
https://doaj.org/article/793d6ab292574ce2b8dfc4897ed38b34
Publikováno v:
Cancer Medicine, Vol 7, Iss 5, Pp 1697-1705 (2018)
Abstract Colorectal cancer (CRC) is a major cause of deaths worldwide but has a good prognosis if detected early. The need for efficient, preferable non‐ or minimally invasive, inexpensive screening tools is therefore critical. We analyzed 12 miRNA
Externí odkaz:
https://doaj.org/article/54eedcf227f144c7a70bc011eea29947
Autor:
Roger Olofsson Bagge, Axel Nelson, Amir Shafazand, Charlotta All-Eriksson, Christian Cahlin, Nils Elander, Hildur Helgadottir, Jens Folke Kiilgaard, Sara Kinhult, Ingrid Ljuslinder, Jan Mattsson, Magnus Rizell, Malin Sternby Eilard, Gustav J. Ullenhag, Jonas A. Nilsson, Lars Ny, Per Lindnér
Publikováno v:
Journal of Clinical Oncology. 41:3042-3050
PURPOSE About half of patients with metastatic uveal melanoma present with isolated liver metastasis, in whom the median survival is 6-12 months. The few systemic treatment options available only moderately prolong survival. Isolated hepatic perfusio
Autor:
Beatrice S. Melin, Melissa L. Bondy, Roger Henriksson, Håkan Hedman, Aysegul Sahin, Abenaa Brewster, Spyros Tsavachidis, Ingrid Ljuslinder, Patricia A. Thompson
Gains and losses at chromosome 3p12-21 are common in breast tumors and associated with patient outcomes. We hypothesized that the LRIG1 gene at 3p14.1, whose product functions in ErbB-family member degradation, is a critical tumor modifier at this lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fd773a0d50e38a51f13d7f9da607d02
https://doi.org/10.1158/0008-5472.c.6505053.v1
https://doi.org/10.1158/0008-5472.c.6505053.v1